Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized for You
we will pick new questions that match your level based on your Timer History
Track Your Progress
every week, we’ll send you an estimated GMAT score based on your performance
Practice Pays
we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Thank you for using the timer!
We noticed you are actually not timing your practice. Click the START button first next time you use the timer.
There are many benefits to timing your practice, including:
Meet AdComs and explore top Master’s programs - MiM, MiF, MSc, MSBA and more. - Application Fee Waivers - Free 1-Week of GMAT Club Tests: - Master's Application Toolkit - Grand Prize Giveaway
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Select the dropdowns below and click "Submit" to add this question to your Error log.
Difficulty:
85%
(hard)
Question Stats:
48%
(02:28)
correct 52%
(02:38)
wrong
based on 615
sessions
History
Date
Time
Result
Not Attempted Yet
Jivas Labs researches and commercially produces two types of drugs, analgesics and opioids. For the first few years after a drug’s commercial production begins, huge investments are made to set up the production and distribution chain for the new drug. As a result, the net profitability, which is calculated by subtracting investment expenses from the revenue from the drug, is negative. The graph represents the projected net profitability for the first 15 years of a newly-introduced analgesic and a newly-introduced opioid.
From each drop-down menu, select the option that creates the most accurate statement about these projections based on the given information.
The projected net profitability of the newly-introduced opioid is least at the end of the year since commercial production.
If net profitability is projected to grow, over the years 16 through 20, at the same rate as in years 10 through 15, the projected net profitability of the newly-introduced analgesic for the seventeenth year is approximately million.
Still interested in this question? Check out the "Best Topics" block below for a better discussion on this exact question, as well as several more related questions.
Thank you for understanding, and happy exploring!
Submit Answer
Start the Timer above, select the dropdowns, and click "Submit" to add this question to your Error log.
Select the dropdowns, and click "Submit" to add this question to your Error log.
1st blank: The opioid is at its lowest at the end of the 5th year - the x-axis represents the number of years since production - so as the lowest point is at x=5 it means that it has been 5 years since they were produced - hence end of 5 years. Hence, answer is "fifth"
2nd blank: slope of the line for analgesic: (10-5)/(15-10) = 1 So for 17th year: y - 10 = 1*(17-15) -> y=12 So, net projected profitability for 17th year will be $12 million.
I was incorrect in Q2 and use the wrong method for translating 100% growth for the next 5 years, meaning 20% per year then at 17th year, got 2(20%) growth. Please kindly explain the right way. thanksss
ExpertsGlobal5
Jivas Labs researches and commercially produces two types of drugs, analgesics and opioids. For the first few years after a drug’s commercial production begins, huge investments are made to set up the production and distribution chain for the new drug. As a result, the net profitability, which is calculated by subtracting investment expenses from the revenue from the drug, is negative. The graph represents the projected net profitability for the first 15 years of a newly-introduced analgesic and a newly-introduced opioid.
From each drop-down menu, select the option that creates the most accurate statement about these projections based on the given information.
The projected net profitability of the newly-introduced opioid is least at the end of the year since commercial production.
If net profitability is projected to grow, over the years 16 through 20, at the same rate as in years 10 through 15, the projected net profitability of the newly-introduced analgesic for the seventeenth year is approximately million.
Q2. From 10-12 years, the increase in net profitability is 2M. So from 15-17 years, the increase will be the same, i.e., 2 At 17th year, value = 15th year value + 2M = 10M + 2M = 12M.
No, wait. The question says "at the end of", not the beginning!! If the question was "which year the opioid was at its lowest", then it should have been fifth. But the slope goes negatively between 4-5 and then it starts growing at 5. Shouldn't the answer be "fourth"?
Archived Topic
Hi there,
This topic has been closed and archived due to inactivity or violation of community quality standards. No more replies are possible here.
Still interested in this question? Check out the "Best Topics" block above for a better discussion on this exact question, as well as several more related questions.